The Immune System – Products

New and improved workflow now available that pairs Revvity’s T-SPOT™.TB test with the Auto-Pure 2400 liquid handling platform. Substantially lowers hands-on time, allowing for increased lab productivity.

Ready-to-use kit expands range of bioanalysis kits, and enables generic detection of immune complexes in rodent samples.

New and improved workflow now available that pairs Revvity’s T-SPOT™.TB test with the Auto-Pure 2400 liquid handling platform. Substantially lowers hands-on time, allowing for increased lab productivity.

To drive the advancement of your antibody drug innovation and development, we offer comprehensive solutions including: target proteins, Fc receptor proteins, kits, beads and services, etc.

This whitepaper explores the tools available to characterize antibody binding to Fc receptors, including quantitative assays to support optimization of therapeutic products.

Peripheral blood mononuclear cells (PBMCs), are increasingly being used in the drug development pipeline for biological therapeutics. However, it is often difficult to align the timing of fresh leukopak availability with the availability of resources to generate experimental data, so PBMCs are usually extracted from fresh leukopaks and then frozen for later use.

Applied Biophysics Forum promises real-world data from nucleic acid drug delivery researchers.

IBD treatment can be a potential market. Our TL1A recombinant proteins and overexpression cell lines are designed to work with you from the drug development perspective. Want to learn more? Explore our webpage and find what’s right for you!

Partnership will use the new Optimer+ platform. Optimer+ EM molecules to be developed to help prevent transplant rejection.

This application note explores B cell isolation, enrichment and characterization methods using specialized platforms for robust and efficient antibody development.